Cantitate/Preț
Produs

Colorectal Liver Metastasis

Editat de Jean-Nicolas Vauthey, Yoshikuni Kawaguchi, René Adam
en Limba Engleză Hardback – 25 noi 2022
This book provides a practically applicable guide to the management of liver metastases in cases of colorectal cancer. It features detailed reviews of the latest diagnostic and therapeutic options. Instruction on how to appropriately apply surgical techniques including two stage hepatectomy as well as both laprascopic and open resection in a variety of scenarios is covered. The use of systemic therapies involving oxaliplatin, immunotherapy and infusional therapy are also described along with a range of surveillance strategies. 
Vauthey and Adam Colorectal Liver Metastasis comprehensively covers the latest advances in how to successfully diagnose and treat colorectal liver metastases and is an indispensable resource for all trainee and practicing medical professionals who encounter these patients within their clinical practice.    


Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 108054 lei  38-45 zile
  Springer International Publishing – 25 noi 2023 108054 lei  38-45 zile
Hardback (1) 137400 lei  38-45 zile
  Springer International Publishing – 25 noi 2022 137400 lei  38-45 zile

Preț: 137400 lei

Preț vechi: 144631 lei
-5% Nou

Puncte Express: 2061

Preț estimativ în valută:
26298 27648$ 21874£

Carte tipărită la comandă

Livrare economică 23-30 decembrie

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783031093227
ISBN-10: 3031093224
Pagini: 569
Ilustrații: XXIV, 569 p. 307 illus., 276 illus. in color.
Dimensiuni: 210 x 279 mm
Greutate: 1.93 kg
Ediția:1st ed. 2022
Editura: Springer International Publishing
Colecția Springer
Locul publicării:Cham, Switzerland

Cuprins

1 History of treatment of colorectal liver metastases 2 Anatomy 3 Exposure 4 Anatomic versus non-anatomic resection 5 Simulation and navigation 6 Advanced techniques in multiple metastases: fiduciary markers and completion ablation 7 Two-stage hepatectomy for biloblar colorectal liver metastases: experience of MD Anderson Cancer Center 8 Two-stage hepatectomy for biloblar colorectal liver metastases: experience of Hôpital Paul-Brousse 9 One-stage hepatectomy for biloblar colorectal liver metastases: experience of the University of Tokyo 10 Associated Liver Partition and Portal vein ligation for Staged hepatectomy (ALLPS) 11 Open resection technique 12 Laparoscopic resection technique: Norwegian experience 13 Laparoscopic resection technique: French experience 14 Laparoscopic resection technique: Japanese experience 15 Is there a place for robotic resection? 16 Advanced resection technique with vascular reconstruction 17 Resection margins 18 R1 vascular resection 19 Prevention and treatment of perihepatic fluid collection including two-step air leak test 20 Synchronous presentation of primary and colorectal liver metastasis: classic, reverse, and combined 21 Approach to synchronous lung and liver metastases and single incision combined resection 22 Perioperative chemotherapy: review of randomized trials and recommended approach 23 The disappearing metastasis 24 Downsizing of unresectable colorectal liver metastasis 25 Is there a place for debulking? 26 Liver transplantation 27 Prognostic model for colorectal liver metastasis 28 Personalized prognostic model (contour model) 29 Conditional recurrence-free survival 30 Repeat Hepatectomy: Rationale and Results 31 Initial systemic chemotherapy for metastatic CRC 32 Treatment refractory metastatic CRC 33 Targeted therapy beyond EGFR and VEGF 34 Adjuvant systemic chemotherapy 35 Immunotherapy 36 Infusional therapy: European experience 37 Infusional therapy: American experience 38 Optimal diagnostic imaging of CLM in surgical candidates 39 Prevention of postoperative liver insufficiency including standardized future liver remnant and kinetic growth rate 40 Portal vein embolization with and without hepatic vein occlusion 41 Radiofrequency ablation, electroporation and microwave ablation 42 Radiation therapy 43 Radioembolization 44 Hepatic injury from chemotherapy 45 Imaging response criteria 46 Pathological response criteria 47 Histopathological patterns of progression and vessel co-option 48 Micrometastasis 49 Liquid biopsy 50 Multigene testing for prognostication and therapeutic actionability 51 Cancer-related signaling pathway and prognosis 52 Intra-operative ultrasound 53 Hybrid room for combined procedures 54 Liver tumor board 55 Role of advanced practice providers in enhancing perioperative and intraoperative patient care 56 Enhanced recovery after liver resection 57 Improved survival after CLM resection over 20 years 58 LiverMetSurvey registry 59 Surveillance strategy and circulating DNA

Notă biografică

Dr. Jean-Nicolas Vauthey is Chief of the Hepato-Pancreato-Biliary Section in the Department of Surgical Oncology at The University of Texas MD Anderson Cancer Center and the Dallas Fort Worth Living Legend in Clinical Cancer Research Chair in Houston, USA. Dr. Vauthey co-authored more than 600 publications in peer-reviewed journals (h-index, 107) and more than 100 reviews and book chapters in major textbooks. Dr. Vauthey’s clinical research focuses on methods to measure and to improve outcome after hepatic resection for hepatobiliary malignancies. Dr. Vauthey proposed a standardized method for calculating the volume of the anticipated liver remnant prior to liver surgery. Dr. Vauthey has evaluated the use of preoperative chemotherapy in the multidisciplinary treatment of patients with hepatic colorectal metastases. He has pioneered the use of 2-stage hepatectomy for patients with advanced metastatic colorectal carcinoma to liver. Dr. Vauthey’s most recent work has focused on somatic mutations, circulating tumor DNA and their role in defining response, treatment, surveillance and prognosis after resection of colorectal liver metastases.
Dr. Yoshikuni Kawaguchi is Deputy Chief (Inpatient Care) of Hepato-Biliary-Pancreatic Surgery Division in the Department of Surgery at The University of Tokyo. Dr. Kawaguchi co-authored more than 130 publications in peer-reviewed journals (h-index, 25). Dr. Kawaguchi’s interest in clinical research is to improve short- and long-term outcomes of patients undergoing surgery for hepato-biliary-pancreatic diseases. Dr. Kawaguchi proposed a novel 3-level classification system for open and minimally-invasive liver resection, which is associated with liver resection complexity and postoperative complications. Dr. Kawaguchi has recently worked with Dr. Vauthey to improve the understanding of multiple somatic mutations of colorectal liver metastases for clinical practices including accurate prognostication after resection and recurrence risk-adjusted surveillance algorithm.

Professor René Adam is president of the Medical Board of the Paul Brousse Hospital, Villejuif, France and head of the Oncological Surgery Unit of the Hepato Biliary Center. Since 1994, he has held the position of professor of surgery at the Faculty of Medicine Kremlin Bicêtre at Paris South University, Paris. Professor Adam’s main fields of activity and research are surgery of the liver, biliary tract and pancreas, and hepatic transplantation. He is particularly involved in the treatment of hepatocellular carcinoma and of liver metastases. 

Textul de pe ultima copertă

This book provides a practically applicable guide to the management of liver metastases in cases of colorectal cancer. It features detailed reviews of the latest diagnostic and therapeutic options. Instruction on how to appropriately apply surgical techniques including two stage hepatectomy as well as both laprascopic and open resection in a variety of scenarios is covered. The use of systemic therapies involving oxaliplatin, immunotherapy and infusional therapy are also described along with a range of surveillance strategies. 
Vauthey and Adam Colorectal Liver Metastasis comprehensively covers the latest advances in how to successfully diagnose and treat colorectal liver metastases and is an indispensable resource for all trainee and practicing medical professionals who encounter these patients within their clinical practice.    



Caracteristici

Covers recent developments in molecular biology and its impact for diagnosing and treating colorectal cancer
Provides a comprehensive overview of the latest surveillance strategies
Features instructional guidance on how to perform a two stage hepatectomy